Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
52
RYHTY Quote, Financials, Valuation and Earnings
Last price:
$8.31
Seasonality move
:
-7.17%
Day range:
$8.31 - $8.31
52-week range:
$6.68 - $13.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.21x
P/B ratio:
0.34x
Volume:
--
Avg. volume:
35
1-year change:
-30.75%
Market cap:
$831M
Revenue:
$423.7M
EPS (TTM):
-$2.31
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RYHTY
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
-- | -- | -- | -- | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RYHTY
Ryman Healthcare Ltd.
|
$8.31 | -- | $831M | -- | $0.00 | 0% | 3.21x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$19.26 | -- | $11.3B | 44.45x | $0.17 | 1.81% | 8.91x |
|
PFGTF
Pacific Edge Ltd.
|
$0.10 | -- | $101.5M | -- | $0.00 | 0% | 8.49x |
|
SMGRF
Summerset Group Holdings Ltd.
|
$7.20 | -- | $1.7B | 7.89x | $0.07 | 1.95% | 8.52x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RYHTY
Ryman Healthcare Ltd.
|
-- | 1.339 | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
3.28% | 0.499 | -- | 1.14x |
|
PFGTF
Pacific Edge Ltd.
|
1.14% | -3.720 | -- | 2.82x |
|
SMGRF
Summerset Group Holdings Ltd.
|
36.6% | -0.055 | -- | 0.11x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RYHTY
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$299.7M | -$209.7M | 18.6% | 19.71% | 40.18% | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -69.68% | -72.02% | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | 5.8% | 12.83% | -- | -- |
Ryman Healthcare Ltd. vs. Competitors
-
Which has Higher Returns RYHTY or AROAF?
Aroa Biosurgery has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of --. Ryman Healthcare Ltd.'s return on equity of -- beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RYHTYRyman Healthcare Ltd.-- -- -- AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About RYHTY or AROAF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Aroa Biosurgery, analysts believe Ryman Healthcare Ltd. is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings RYHTYRyman Healthcare Ltd.0 0 0 AROAFAroa Biosurgery0 0 0 -
Is RYHTY or AROAF More Risky?
Ryman Healthcare Ltd. has a beta of 0.577, which suggesting that the stock is 42.29% less volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock RYHTY or AROAF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RYHTY or AROAF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Aroa Biosurgery quarterly revenues of --. Ryman Healthcare Ltd.'s net income of -- is lower than Aroa Biosurgery's net income of --. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.21x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RYHTYRyman Healthcare Ltd.3.21x -- -- -- AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns RYHTY or FSPKF?
Fisher & Paykel Healthcare Corp. Ltd. has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of 29.46%. Ryman Healthcare Ltd.'s return on equity of -- beat Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71%.
Company Gross Margin Earnings Per Share Invested Capital RYHTYRyman Healthcare Ltd.-- -- -- FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B -
What do Analysts Say About RYHTY or FSPKF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Fisher & Paykel Healthcare Corp. Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Fisher & Paykel Healthcare Corp. Ltd., analysts believe Ryman Healthcare Ltd. is more attractive than Fisher & Paykel Healthcare Corp. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RYHTYRyman Healthcare Ltd.0 0 0 FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 -
Is RYHTY or FSPKF More Risky?
Ryman Healthcare Ltd. has a beta of 0.577, which suggesting that the stock is 42.29% less volatile than S&P 500. In comparison Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.201, suggesting its more volatile than the S&P 500 by 20.107%.
-
Which is a Better Dividend Stock RYHTY or FSPKF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fisher & Paykel Healthcare Corp. Ltd. offers a yield of 1.81% to investors and pays a quarterly dividend of $0.17 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd. pays out 77.61% of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RYHTY or FSPKF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues of $723.8M. Ryman Healthcare Ltd.'s net income of -- is lower than Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Fisher & Paykel Healthcare Corp. Ltd.'s PE ratio is 44.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.21x versus 8.91x for Fisher & Paykel Healthcare Corp. Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RYHTYRyman Healthcare Ltd.3.21x -- -- -- FSPKFFisher & Paykel Healthcare Corp. Ltd.8.91x 44.45x $723.8M $213.2M
-
Which has Higher Returns RYHTY or PFGTF?
Pacific Edge Ltd. has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of --. Ryman Healthcare Ltd.'s return on equity of -- beat Pacific Edge Ltd.'s return on equity of -72.02%.
Company Gross Margin Earnings Per Share Invested Capital RYHTYRyman Healthcare Ltd.-- -- -- PFGTFPacific Edge Ltd.-- -- $15.1M -
What do Analysts Say About RYHTY or PFGTF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Edge Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Pacific Edge Ltd., analysts believe Ryman Healthcare Ltd. is more attractive than Pacific Edge Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RYHTYRyman Healthcare Ltd.0 0 0 PFGTFPacific Edge Ltd.0 0 0 -
Is RYHTY or PFGTF More Risky?
Ryman Healthcare Ltd. has a beta of 0.577, which suggesting that the stock is 42.29% less volatile than S&P 500. In comparison Pacific Edge Ltd. has a beta of -3.301, suggesting its less volatile than the S&P 500 by 430.112%.
-
Which is a Better Dividend Stock RYHTY or PFGTF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pacific Edge Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Pacific Edge Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RYHTY or PFGTF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Pacific Edge Ltd. quarterly revenues of --. Ryman Healthcare Ltd.'s net income of -- is lower than Pacific Edge Ltd.'s net income of --. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Pacific Edge Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.21x versus 8.49x for Pacific Edge Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RYHTYRyman Healthcare Ltd.3.21x -- -- -- PFGTFPacific Edge Ltd.8.49x -- -- --
-
Which has Higher Returns RYHTY or SMGRF?
Summerset Group Holdings Ltd. has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of --. Ryman Healthcare Ltd.'s return on equity of -- beat Summerset Group Holdings Ltd.'s return on equity of 12.83%.
Company Gross Margin Earnings Per Share Invested Capital RYHTYRyman Healthcare Ltd.-- -- -- SMGRFSummerset Group Holdings Ltd.-- -- $2.6B -
What do Analysts Say About RYHTY or SMGRF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Summerset Group Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Summerset Group Holdings Ltd., analysts believe Ryman Healthcare Ltd. is more attractive than Summerset Group Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RYHTYRyman Healthcare Ltd.0 0 0 SMGRFSummerset Group Holdings Ltd.0 0 0 -
Is RYHTY or SMGRF More Risky?
Ryman Healthcare Ltd. has a beta of 0.577, which suggesting that the stock is 42.29% less volatile than S&P 500. In comparison Summerset Group Holdings Ltd. has a beta of -0.437, suggesting its less volatile than the S&P 500 by 143.654%.
-
Which is a Better Dividend Stock RYHTY or SMGRF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Summerset Group Holdings Ltd. offers a yield of 1.95% to investors and pays a quarterly dividend of $0.07 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Summerset Group Holdings Ltd. pays out 16.94% of its earnings as a dividend. Summerset Group Holdings Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RYHTY or SMGRF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Summerset Group Holdings Ltd. quarterly revenues of --. Ryman Healthcare Ltd.'s net income of -- is lower than Summerset Group Holdings Ltd.'s net income of --. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Summerset Group Holdings Ltd.'s PE ratio is 7.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.21x versus 8.52x for Summerset Group Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RYHTYRyman Healthcare Ltd.3.21x -- -- -- SMGRFSummerset Group Holdings Ltd.8.52x 7.89x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 4.13% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is up 12.87% over the past day.
